Glucagon Secretion Source: A Descriptive Summary of Its Origin
Title: Glucagon Secretion Source: A Descriptive Summary of Its Origin Abstract: Glucagon is secreted from the pancreatic alpha cells, a critical origin for glucose homeostasis. In the peptide product market, this hormone is synthetically produced via recombinant DNA technology, offering high purity (>98%) and batch consistency. Compared to animal-derived alternatives, synthetic glucagon demonstrates superior stability and reduced immunogenicity. Current market trends show a 7.2% CAGR (2023-2030) driven by diabetes and hypoglycemia management. Leading brands like Novo Nordisk and Eli Lilly dominate, with FDA and EMA certifications ensuring quality. Key selection criteria include purity, endotoxin levels, and lyophilized formulation for logistics. Industry data indicates a shift toward multi-dose pen devices, enhancing patient compliance.